Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.

@article{Lachmann2013MyeloprotectionBC,
  title={Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.},
  author={Nico Lachmann and Sebastian Brennig and Ruhi Phaltane and Michael Flasshove and Dagmar Dilloo and Thomas Moritz},
  journal={Neoplasia},
  year={2013},
  volume={15 3},
  pages={239-48}
}
Gene transfer of drug resistance (CTX-R) genes can be used to protect the hematopoietic system from the toxicity of anticancer chemotherapy and this concept recently has been proven by overexpression of a mutant O(6)-methylguaninemethyltransferase in the hematopoietic system of glioblastoma patients treated with temozolomide. Given its protection capacity against such relevant drugs as cytosine arabinoside (ara-C), gemcitabine, decitabine, or azacytidine and the highly hematopoiesis-specific… CONTINUE READING
8 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…